Generic Name: Linagliptin
Brand Name: Trajenta
Manufacturer: Boehringer Ingelheim Canada
Indications: Diabetes mellitus, Type 2
Submission Type: New
Project Status: Complete
Date Recommendation Issued: February 15, 2012
Recommendation Type: List with clinical criteria and/or conditions